MaltSci 麦伴科研

Appearance

Popular Reports / Genomics

This report is written by MaltSci based on the latest literature and research findings

How does multi-omics integration advance genomics? ​

Abstract ​

The integration of multi-omics data has revolutionized the field of genomics, offering unprecedented insights into the complex biological systems that govern health and disease. Traditional single-omics approaches often fall short in capturing the multifaceted interactions and regulatory networks that underpin biological processes, highlighting the need for a more holistic data integration strategy. Multi-omics integration combines various omics layers—genomics, transcriptomics, proteomics, metabolomics, and epigenomics—to provide a comprehensive understanding of biological systems. This integrative approach has significant implications for personalized medicine, enabling the identification of novel biomarkers for diseases and informing targeted therapies. Current research has made notable strides in applying multi-omics strategies to cancer research, metabolic disorders, and infectious diseases, showcasing its potential to enhance our understanding of disease mechanisms and improve clinical outcomes. However, challenges such as data heterogeneity, variability in sample processing, and computational complexities persist, necessitating ongoing efforts to develop standardized protocols and robust analytical frameworks. Future directions in multi-omics research will focus on technological advancements, collaborative initiatives, and ethical considerations to maximize the integration's potential in advancing genomics and personalized healthcare.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Overview of Multi-Omics Integration
    • 2.1 Definition and Importance of Multi-Omics
    • 2.2 Key Omics Layers: Genomics, Transcriptomics, Proteomics, Metabolomics, and Epigenomics
  • 3 Methodologies for Multi-Omics Integration
    • 3.1 Data Acquisition and Preprocessing
    • 3.2 Integration Techniques: Statistical and Computational Approaches
    • 3.3 Tools and Platforms for Multi-Omics Analysis
  • 4 Case Studies in Multi-Omics Integration
    • 4.1 Applications in Cancer Research
    • 4.2 Role in Metabolic Disorders
    • 4.3 Insights into Infectious Diseases
  • 5 Challenges and Limitations
    • 5.1 Data Heterogeneity and Standardization
    • 5.2 Computational Challenges and Data Integration
    • 5.3 Ethical Considerations in Multi-Omics Research
  • 6 Future Directions in Multi-Omics Research
    • 6.1 Advances in Technology and Methodology
    • 6.2 Personalized Medicine and Clinical Applications
    • 6.3 Collaborative Efforts and Data Sharing Initiatives
  • 7 Summary

1 Introduction ​

The integration of multi-omics data has revolutionized the field of genomics, offering unprecedented insights into the complex biological systems that govern health and disease. As the study of biological phenomena becomes increasingly intricate, the limitations of single-omics approaches—focused on genomics, transcriptomics, proteomics, metabolomics, and epigenomics—have become apparent. These traditional methodologies often fail to capture the multifaceted interactions and regulatory networks that underpin biological processes and disease mechanisms. Consequently, the need for a more holistic approach to data integration has emerged, where various omics layers are analyzed in concert to provide a comprehensive understanding of biological systems [1][2].

The significance of multi-omics integration extends beyond basic research; it has profound implications for personalized medicine and targeted therapies. By elucidating the intricate interplay between different molecular layers, researchers can identify novel biomarkers for diseases, enabling earlier diagnosis and more effective treatment strategies [3][4]. Furthermore, the increasing availability of high-throughput technologies and advanced computational methods has facilitated the collection and analysis of vast amounts of biological data, allowing for the systematic exploration of the complex interactions that define health and disease [5][6].

Current research in multi-omics integration has made significant strides, particularly in areas such as cancer research, metabolic disorders, and infectious diseases. For instance, multi-omics approaches have been employed to characterize tumor heterogeneity, identify molecular subtypes, and uncover potential therapeutic targets [7][8]. Moreover, the integration of spatial multi-omics has further enhanced our understanding of the cellular microenvironment, providing insights into the spatial organization of molecular interactions [2]. These advancements underscore the potential of multi-omics to transform our understanding of complex diseases and improve clinical outcomes.

Despite these advancements, the field of multi-omics integration faces several challenges. Data heterogeneity, variability in sample processing, and the complexity of computational analyses pose significant obstacles to the effective integration of multi-omics datasets [3][4]. Additionally, ethical considerations regarding data privacy and the interpretation of integrative analyses remain pressing issues [9]. Addressing these challenges is critical for the successful implementation of multi-omics strategies in clinical settings and for realizing their full potential in advancing personalized medicine [1][10].

This review is organized as follows: Section 2 provides an overview of multi-omics integration, defining its importance and discussing the key omics layers involved. Section 3 outlines the methodologies employed in multi-omics integration, including data acquisition, preprocessing, and various integration techniques. In Section 4, we present significant case studies that illustrate the applications of multi-omics in cancer research, metabolic disorders, and infectious diseases. Section 5 addresses the challenges and limitations of multi-omics integration, while Section 6 explores future directions in this rapidly evolving field, including advances in technology and collaborative efforts for data sharing. Finally, Section 7 summarizes the key insights from this review, emphasizing the transformative potential of multi-omics integration in advancing the frontiers of genomics research. By synthesizing existing literature and presenting a cohesive overview, this report aims to provide valuable insights into how multi-omics integration is reshaping our understanding of biological systems and disease mechanisms.

2 Overview of Multi-Omics Integration ​

2.1 Definition and Importance of Multi-Omics ​

Multi-omics integration represents a transformative approach in the field of genomics, enhancing our understanding of complex biological systems by combining various omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This integrative methodology is essential for elucidating the intricate interactions and regulatory mechanisms that underlie biological processes, ultimately advancing both basic and applied research in genomics.

The importance of multi-omics lies in its ability to provide a comprehensive view of the molecular landscape of organisms. By integrating diverse datasets, researchers can uncover the multifaceted relationships between genes, their expression products, and the resulting phenotypic traits. For instance, the integration of genomic data with transcriptomic and proteomic information allows for a more accurate characterization of gene function and regulation, revealing how genetic variations contribute to observable traits and disease states (Luo et al. 2024; Liu et al. 2024).

Multi-omics integration is particularly crucial in the context of complex diseases, where single-omics approaches often fall short in capturing the full biological complexity. The integration of data across different omics layers enables a holistic understanding of disease mechanisms, facilitating the identification of novel biomarkers and therapeutic targets. For example, in cancer research, multi-omics strategies have been instrumental in revealing the molecular underpinnings of tumor heterogeneity and treatment resistance, thus informing personalized medicine approaches (Yan et al. 2025; Menyhárt & Győrffy 2021).

Furthermore, advancements in computational methodologies, such as deep learning and graph neural networks, are pivotal for the effective synthesis and interpretation of multi-omics data. These technologies enable researchers to manage the inherent challenges of data heterogeneity and scale, allowing for the development of robust models that can predict complex traits and disease outcomes (Luo et al. 2024; Alif & Zhang 2025). The application of AI-driven bioinformatics tools enhances the integration process, facilitating the extraction of meaningful insights from large and complex datasets (Srivastava 2025).

In summary, multi-omics integration significantly advances genomics by providing a comprehensive framework for understanding the interactions within biological systems. It enables researchers to dissect the regulatory networks that govern gene expression and function, leading to improved diagnostic and therapeutic strategies across various fields, including crop improvement, cancer research, and personalized medicine. As multi-omics technologies continue to evolve, their integration will play an increasingly critical role in shaping the future of genomic research and its applications in health and disease (Fan et al. 2025; Zhao et al. 2025).

2.2 Key Omics Layers: Genomics, Transcriptomics, Proteomics, Metabolomics, and Epigenomics ​

Multi-omics integration represents a transformative approach in the field of genomics, enhancing our understanding of complex biological systems by combining data from various omics layers, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This integrative strategy facilitates a more comprehensive analysis of biological phenomena, allowing researchers to uncover intricate molecular interactions and regulatory mechanisms that are crucial for both health and disease.

Genomics, the study of the complete set of DNA within an organism, serves as the foundational layer in multi-omics integration. By analyzing genomic data, researchers can identify genetic variations that may contribute to phenotypic traits or disease susceptibility. However, genomics alone often lacks the ability to explain how these genetic variations manifest at the molecular level. This is where transcriptomics, the study of RNA transcripts produced by the genome, plays a critical role. Transcriptomic data provide insights into gene expression patterns, revealing how genetic information is translated into functional products. The integration of genomic and transcriptomic data allows for a better understanding of the functional consequences of genetic variations and the regulation of gene expression.

Proteomics, which focuses on the large-scale study of proteins, adds another layer of complexity to multi-omics integration. Proteins are the direct effectors of cellular functions, and their abundance, modifications, and interactions can significantly influence cellular behavior. By integrating proteomic data with genomic and transcriptomic information, researchers can elucidate the pathways and networks that drive biological processes, thereby identifying potential biomarkers for disease diagnosis and therapeutic targets.

Metabolomics, the study of small molecules or metabolites within biological systems, complements the other omics layers by providing a snapshot of the metabolic state of an organism. Integrating metabolomic data with genomic, transcriptomic, and proteomic information allows for a more holistic view of cellular functions and the biochemical pathways that underlie physiological and pathological conditions. This multi-faceted approach can reveal how genetic and environmental factors converge to influence metabolism and contribute to disease states.

Epigenomics, which examines the chemical modifications of DNA and histones that regulate gene expression without altering the underlying DNA sequence, is also essential for multi-omics integration. Epigenetic modifications can affect how genes are expressed in response to environmental stimuli, thereby influencing an organism's phenotype. By incorporating epigenomic data into the multi-omics framework, researchers can gain insights into the regulatory mechanisms that govern gene expression and their implications for health and disease.

The advancement of multi-omics integration is facilitated by technological innovations in data collection and analysis. For instance, the emergence of high-throughput sequencing technologies has dramatically increased the volume of available genomic, transcriptomic, and proteomic data. Additionally, advancements in computational methodologies, such as machine learning and deep learning, are enabling more effective integration and interpretation of multi-omics data. These computational tools can help identify patterns and relationships across different omics layers, leading to the discovery of novel biomarkers and therapeutic targets.

Despite the significant promise of multi-omics integration, challenges remain, including data heterogeneity, the complexity of integrating diverse data types, and the need for robust analytical frameworks. Addressing these challenges will require interdisciplinary collaboration among researchers in genomics, bioinformatics, and computational biology, as well as the development of standardized protocols for data collection and analysis.

In summary, multi-omics integration enhances genomics by providing a comprehensive view of biological systems, elucidating the interactions between different molecular layers, and facilitating the identification of novel biomarkers and therapeutic targets. As technologies and methodologies continue to evolve, the potential for multi-omics approaches to revolutionize our understanding of biology and improve clinical outcomes will only increase[2][4][5].

3 Methodologies for Multi-Omics Integration ​

3.1 Data Acquisition and Preprocessing ​

Multi-omics integration represents a transformative advancement in genomics, enabling researchers to synthesize data from various biological layers—genomics, transcriptomics, proteomics, metabolomics, and epigenomics—into a cohesive understanding of biological systems. This approach facilitates the exploration of complex interactions and regulatory mechanisms that underlie various biological processes, significantly enhancing our comprehension of genomics.

The methodologies for multi-omics integration are diverse and evolving, often leveraging advanced computational techniques to manage and interpret the large volumes of data generated from different omics layers. For instance, recent advancements in deep learning, graph neural networks (GNNs), and generative adversarial networks (GANs) have proven essential for effective data synthesis and interpretation in multi-omics research. These methodologies allow for the identification of intricate interactions among biomolecules, which are crucial for understanding the regulatory networks that dictate phenotypic traits and disease mechanisms (Luo et al. 2024) [4].

Data acquisition and preprocessing are critical steps in the multi-omics integration process. The collection of omics data requires high-throughput technologies such as next-generation sequencing (NGS), mass spectrometry, and various bioinformatics tools to ensure that data from different omics platforms are comparable and integrable. The preprocessing phase involves standardizing the data to account for variability in measurement techniques and conditions, thereby enhancing the reliability of subsequent analyses. For example, normalization techniques are applied to adjust for batch effects and technical variations, ensuring that the integrated datasets accurately reflect biological variations rather than artifacts of the data collection process (Yang et al. 2021) [11].

Moreover, the integration of multi-omics data not only aids in elucidating the genetic and epigenetic landscapes associated with various traits but also enhances the predictive capabilities regarding disease susceptibility and treatment responses. By employing multi-omics strategies, researchers can construct more robust models that incorporate multiple biological dimensions, leading to improved identification of biomarkers and therapeutic targets (Zhang et al. 2022) [6].

The holistic framework provided by multi-omics integration has profound implications for advancing genomic research. It facilitates a comprehensive understanding of the molecular basis of diseases, enabling personalized medicine approaches that are tailored to individual genetic profiles and environmental interactions. As the field continues to evolve, the integration of single-cell multi-omics and artificial intelligence techniques is expected to further refine our capabilities in genomics, allowing for more precise diagnostics and targeted therapeutic interventions (Srivastava 2025) [9].

In summary, multi-omics integration enhances genomics through advanced methodologies that facilitate comprehensive data synthesis, rigorous preprocessing techniques that ensure data quality, and a holistic understanding of biological systems that drive innovations in personalized medicine and therapeutic strategies.

3.2 Integration Techniques: Statistical and Computational Approaches ​

Multi-omics integration significantly advances genomics by providing a comprehensive understanding of biological systems through the synergistic combination of data from various omics layers, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This integration facilitates the elucidation of complex interactions and regulatory mechanisms underlying biological processes, ultimately enhancing the ability to address challenges in genomics and personalized medicine.

The methodologies for multi-omics integration can be broadly categorized into statistical and computational approaches. Statistical methods often involve the use of correlation-based techniques to identify relationships between different omics layers. For instance, integrating transcriptomic data with genomic data can reveal how gene expression levels correlate with genetic variations, thus shedding light on regulatory networks. Similarly, proteomic data can be integrated to understand how protein expression levels are influenced by both genetic and transcriptomic factors, allowing researchers to construct a more complete picture of cellular functions and disease mechanisms.

Computational approaches have gained prominence in multi-omics integration, leveraging advanced algorithms and machine learning techniques to process and analyze large datasets. Recent advancements in computational methodologies, such as deep learning, graph neural networks (GNNs), and generative adversarial networks (GANs), have significantly improved the synthesis and interpretation of multi-omics data [4]. These methods enable the effective integration of diverse omics datasets, addressing challenges related to data heterogeneity and the need for robust models. For example, graph-based approaches can model complex interactions between different omics layers, capturing both intra-omics and inter-omics dependencies, which is crucial for understanding multifactorial diseases [12].

One specific computational framework introduced for enhancing multi-omics integration is SynOmics, which utilizes graph convolutional networks to construct omics networks in the feature space. This framework allows for simultaneous learning of both within-omics and cross-omics relationships, thereby improving the depth of integration and facilitating biomarker discovery [12]. Such innovative approaches highlight the potential of computational techniques to overcome the limitations of traditional statistical methods, providing deeper insights into the molecular underpinnings of complex biological phenomena.

Moreover, multi-omics integration has proven to be invaluable in cancer research, where it helps in identifying molecular pathways and biomarkers crucial for early detection, prognostic evaluation, and personalized treatment [13]. By integrating genomic, transcriptomic, and proteomic data, researchers can elucidate how alterations in gene expression and protein interactions contribute to cancer progression and treatment resistance. This integrative approach not only enhances our understanding of cancer biology but also fosters the development of innovative therapeutic strategies, ultimately improving patient outcomes.

In summary, the integration of multi-omics data through statistical and computational methodologies significantly advances genomics by providing a holistic view of biological systems. These approaches facilitate the identification of complex interactions and regulatory networks, enhancing our understanding of health and disease while paving the way for personalized medicine and targeted therapies. The ongoing evolution of multi-omics technologies and methodologies promises to further deepen our insights into the molecular mechanisms that govern biological processes.

3.3 Tools and Platforms for Multi-Omics Analysis ​

Multi-omics integration significantly advances genomics by providing a comprehensive understanding of biological systems through the synthesis of data from various omics layers, including genomics, transcriptomics, proteomics, and metabolomics. This integrative approach enables researchers to uncover complex interactions and regulatory mechanisms that govern biological processes, which are often obscured when analyzing single omics data independently.

The methodologies for multi-omics integration encompass a variety of computational strategies aimed at harmonizing disparate datasets. Recent advancements in computational methodologies, such as deep learning, graph neural networks (GNNs), and generative adversarial networks (GANs), have been pivotal in facilitating effective synthesis and interpretation of multiomics data. These methods address critical challenges like data heterogeneity and scalability, enabling researchers to construct robust, interpretable models that can accurately reflect the underlying biological phenomena [4].

One notable framework for multi-omics integration is SynOmics, which employs a graph convolutional network to enhance the integration process by constructing omics networks in the feature space. This model captures both within- and cross-omics dependencies, allowing for simultaneous learning of intra-omics and inter-omics relationships. The parallel learning strategy utilized by SynOmics has shown superior performance in various biomedical classification tasks, thus highlighting its potential for biomarker discovery and clinical applications [12].

Furthermore, the role of artificial intelligence (AI) in multi-omics analysis cannot be overstated. AI-driven bioinformatics tools facilitate the quantitative integration of multi-omics data, providing insights into disease-associated molecular mechanisms and enhancing precision medicine efforts. These tools aid in early disease detection, biomarker discovery, and the identification of molecular targets for drug development [9]. For instance, GREMI is an explainable multi-omics integration framework designed to improve disease prediction and module identification, focusing on both prediction accuracy and the discovery of meaningful biomarkers [14].

In terms of tools and platforms for multi-omics analysis, a variety of open-source tools and databases have been developed to support researchers in their endeavors. These tools are designed to handle the complexities associated with multi-omics data, offering functionalities for data integration, analysis, and visualization. Notably, advancements in machine learning and deep learning have facilitated the development of user-friendly interfaces that allow researchers, even those new to multi-omics, to effectively analyze and interpret their data [8].

The integration of multi-omics data not only enhances our understanding of genomics but also addresses the limitations of traditional single-omics approaches. By providing a holistic view of biological systems, multi-omics integration fosters the development of personalized therapies and innovative treatment strategies, ultimately improving patient outcomes in precision medicine [10][13]. The ongoing evolution of methodologies and tools for multi-omics analysis promises to further advance the field, offering new insights into the complexities of biological systems and disease mechanisms.

4 Case Studies in Multi-Omics Integration ​

4.1 Applications in Cancer Research ​

Multi-omics integration significantly advances genomics by offering a comprehensive framework for understanding the complex biological processes underlying cancer. This integration involves the simultaneous analysis of multiple omics layers—genomics, transcriptomics, proteomics, metabolomics, and epigenomics—which collectively provide a more holistic view of tumor biology compared to single-omics approaches.

Recent studies illustrate the transformative potential of multi-omics integration in cancer research. For instance, innovative multi-omics frameworks have been employed to classify cancers into subtypes, refine survival predictions, and elucidate key pathophysiological processes across various molecular layers. This has been particularly evident in the realm of prostate cancer, where multi-omics methodologies have enhanced the identification of molecular pathways and biomarkers crucial for early detection, prognostic evaluation, and personalized treatment strategies (Yan et al. 2025) [13]. By integrating genomic, transcriptomic, proteomic, and metabolomic data, researchers have been able to identify novel therapeutic targets and develop innovative treatment modalities, such as precision medicine (Hachem et al. 2024) [15].

In another case, multi-omics approaches have proven invaluable in small-cell lung cancer (SCLC) research. The integration of genomics, transcriptomics, and proteomics allows for a more nuanced understanding of the disease's pathogenesis and progression, ultimately leading to the identification of novel therapeutics and biomarkers (Zhao et al. 2024) [16]. Such comprehensive analyses are crucial for addressing the high heterogeneity observed in cancers, which complicates early diagnosis and treatment decisions.

Moreover, multi-omics integration has been highlighted as a critical tool for enhancing early cancer detection. By leveraging genomic, transcriptomic, proteomic, and metabolomic data, researchers can improve the sensitivity and specificity of diagnostic methods, thereby facilitating better patient outcomes (Milner & Lennerz 2024) [10]. This is particularly relevant given the challenges associated with current diagnostic techniques, which often lack the precision needed to identify early-stage cancers effectively.

Despite the remarkable advantages of multi-omics integration, several challenges persist in its clinical implementation. These include the uneven maturity of different omics approaches and the gap between the generation of large datasets and the capacity to process this data. Initiatives aimed at standardizing sample processing and analytical pipelines, along with multidisciplinary training for experts in data analysis and interpretation, are crucial for translating theoretical findings into practical applications (Chakraborty et al. 2024) [17].

In conclusion, multi-omics integration stands as a powerful advancement in genomics, particularly in cancer research. It facilitates a more comprehensive understanding of tumor biology, aids in the identification of biomarkers and therapeutic targets, and enhances diagnostic accuracy. As the field continues to evolve, addressing the challenges associated with data integration and clinical application will be vital for realizing the full potential of multi-omics in improving patient outcomes across various cancer types.

4.2 Role in Metabolic Disorders ​

Multi-omics integration significantly advances genomics by providing a comprehensive understanding of the complex biological networks that underlie various metabolic disorders. This integrative approach combines data from genomics, transcriptomics, proteomics, and metabolomics, allowing researchers to elucidate the multifaceted interactions between genes, proteins, and metabolites that contribute to disease mechanisms.

A prominent example of multi-omics integration is seen in the study of methylmalonic aciduria (MMA), an inherited metabolic disorder characterized by the accumulation of methylmalonic acid in the body. A recent study by Fu et al. (2025) utilized multi-omics data from 230 individuals (210 patients with MMA and 20 controls) to explore the molecular perturbations associated with the disorder. By integrating genomic, transcriptomic, proteomic, and metabolomic profiles with biochemical and clinical data, the researchers were able to identify significant disruptions in metabolic pathways, particularly highlighting the role of glutathione metabolism in the pathogenesis of MMA. The study also revealed compromised lysosomal function in MMA patients, underscoring the importance of integrating diverse omics layers to obtain a holistic view of the disease's molecular basis [18].

Another significant contribution of multi-omics integration is illustrated in the context of gastrointestinal tumors, which exhibit high heterogeneity and pose challenges for early diagnosis and treatment. Liu et al. (2025) reviewed advancements in multi-omics technologies, demonstrating how genomics can reveal genetic characteristics of tumors, while transcriptomics helps identify molecular subtypes and potential therapeutic targets. Proteomics provides insights into the immune microenvironment, and metabolomics offers biomarkers for early diagnosis. By integrating these various data types, researchers can achieve a panoramic view of the driver mutations, signaling pathways, and metabolic-immune interactions involved in tumor progression [3].

Moreover, multi-omics approaches have proven essential in understanding specialized metabolic pathways in medicinal plants, as highlighted by Wang et al. (2024). Their review discusses how integrating genomics, transcriptomics, proteomics, and metabolomics has accelerated the understanding of biosynthetic gene clusters and metabolic pathways. This integrated perspective is crucial for uncovering the regulatory networks that govern specialized metabolite production, which is vital for developing therapeutic agents from plant resources [19].

The integration of multi-omics not only enhances the understanding of metabolic disorders but also facilitates the identification of novel biomarkers and therapeutic targets. This comprehensive approach is pivotal for advancing precision medicine, as it allows for the development of tailored treatments based on the intricate interplay of genetic, transcriptomic, proteomic, and metabolomic data. As such, multi-omics integration represents a transformative advancement in genomics, providing deeper insights into the biological underpinnings of diseases and guiding the development of more effective diagnostic and therapeutic strategies.

4.3 Insights into Infectious Diseases ​

Multi-omics integration represents a transformative approach in the field of genomics, particularly in understanding infectious diseases. This strategy combines various omics technologies—such as genomics, transcriptomics, proteomics, and metabolomics—to provide a comprehensive overview of biological systems and their interactions, thereby enhancing our understanding of pathogen behavior, host responses, and disease mechanisms.

In the context of infectious diseases, multi-omics integration offers several advantages. Firstly, it enables the identification and characterization of pathogens through a detailed analysis of their genetic makeup and evolutionary relationships. This is crucial for understanding how pathogens establish themselves in naïve populations, which can adversely affect reproduction, productivity, and health in both companion and food-producing animals. As noted by Elrashedy et al. (2025), the integration of bioinformatics and next-generation sequencing (NGS) technologies facilitates the assembly of complete genomes and phylogenetic analyses, thereby improving our ability to diagnose and investigate viral diseases in animals [20].

Furthermore, multi-omics integration deepens our understanding of the molecular mechanisms driving infections. By combining data from various omics layers, researchers can elucidate how different biological pathways interact during an infection, which can lead to the discovery of novel therapeutic targets and biomarkers. For instance, Ali et al. (2024) highlight how multi-omics approaches enhance the detection of pathogenic genetic variants and help decipher molecular mechanisms involved in rare diseases, which can be extrapolated to study the complexities of infectious diseases [21].

Moreover, the application of spatial multi-omics has been particularly significant in infectious disease research. Liu et al. (2024) emphasize that spatial multi-omics addresses the limitations of traditional single-cell sequencing by retaining the spatial context of cell populations, thereby providing insights into the interactions between intracellular and intercellular molecular mechanisms involved in disease [2]. This spatial dimension is crucial for understanding how infections spread and how host tissues respond to pathogens.

In addition to enhancing our understanding of infectious diseases, multi-omics integration also supports the development of precision medicine strategies. Srivastava (2025) discusses how integrating multi-omics data can lead to more personalized approaches in disease therapeutics, allowing for early disease detection, biomarker discovery, and the identification of molecular targets for drug development [9]. This personalized approach is vital in the context of infectious diseases, where patient responses can vary significantly based on genetic and environmental factors.

In conclusion, multi-omics integration advances genomics by providing a holistic view of the biological complexities associated with infectious diseases. Through the integration of various omics technologies, researchers can better understand pathogen-host interactions, identify new therapeutic targets, and ultimately enhance patient outcomes in infectious disease management. The continuous development of these integrative strategies holds great promise for the future of genomics and precision medicine in combating infectious diseases.

5 Challenges and Limitations ​

5.1 Data Heterogeneity and Standardization ​

Multi-omics integration significantly advances genomics by enabling a comprehensive understanding of biological systems through the synthesis of data from various omics layers, including genomics, transcriptomics, proteomics, and metabolomics. This integrative approach allows researchers to uncover complex interactions and regulatory mechanisms that individual omics analyses may overlook. For instance, the combination of genomic data with transcriptomic and proteomic information provides deeper insights into gene expression regulation and protein function, which is essential for understanding the molecular underpinnings of diseases and developing personalized therapeutic strategies [22][23].

However, the integration of multi-omics data is fraught with challenges, particularly concerning data heterogeneity and standardization. Data heterogeneity arises from the diverse nature of omics technologies, which can produce datasets with varying formats, scales, and measurement units. This variability complicates the integration process, as researchers must reconcile these differences to create a cohesive dataset for analysis. Furthermore, the lack of standardized protocols for data collection and processing across different studies leads to inconsistencies that can hinder the comparability of results and the reproducibility of findings [4][7].

Standardization is crucial for ensuring that multi-omics datasets are comparable and interpretable. Without established guidelines for data generation, normalization, and analysis, the integration of multi-omics data can lead to misleading conclusions. For example, different laboratories may employ varying methodologies for sample preparation, data acquisition, and analytical techniques, resulting in datasets that are not directly comparable. Consequently, addressing these challenges requires collaborative efforts to develop universal standards and best practices for multi-omics research [8][9].

Moreover, computational scalability poses another significant limitation in multi-omics integration. As the volume of data generated from high-throughput technologies continues to increase, the computational resources required for data integration and analysis also grow. This necessitates the development of advanced computational tools and algorithms capable of efficiently handling large, complex datasets while maintaining accuracy and reliability [2][10].

In summary, while multi-omics integration represents a powerful advancement in genomics, enabling a more holistic understanding of biological systems, it faces considerable challenges related to data heterogeneity, standardization, and computational scalability. Addressing these issues is vital for maximizing the potential of multi-omics approaches in biomedical research and personalized medicine [24][25].

5.2 Computational Challenges and Data Integration ​

Multi-omics integration represents a transformative advancement in the field of genomics, providing a comprehensive understanding of biological systems by combining data from various omics layers, including genomics, transcriptomics, proteomics, and metabolomics. This integrative approach enhances the ability to decipher complex biological interactions and regulatory mechanisms underlying diseases, thus facilitating precision medicine and personalized treatment strategies.

One of the primary advancements afforded by multi-omics integration is its capability to offer deep insights into disease-associated molecular mechanisms. By accounting for individual omics profiles, multi-omics enables early disease detection and prevention, aids in biomarker discovery for diagnosis, prognosis, and treatment monitoring, and identifies molecular targets for innovative drug development or the repurposing of existing therapies (Srivastava 2025) [9]. The integration of diverse omics data allows researchers to uncover intricate relationships among different molecular layers, thereby elucidating the underlying biology of complex diseases such as cancer (Menyhárt & Győrffy 2021) [7].

Despite its promising potential, the integration of multi-omics data presents significant challenges, particularly computational challenges related to data integration. The complexity of quantitative integration of multiomics data necessitates specialized computational methods to handle the vast and heterogeneous datasets generated from different omics technologies. These challenges include data heterogeneity, scalability, and the requirement for robust, interpretable models (Luo et al. 2024) [4]. The lack of standardized protocols for data processing and analysis further complicates the integration process, leading to difficulties in deriving meaningful insights from the combined datasets (Wolde et al. 2025) [26].

Additionally, the computational resources required for multi-omics integration are substantial, which poses a barrier to widespread clinical application. The complexity of model tuning and the need for advanced bioinformatics tools to facilitate the integration of diverse omics data also present significant hurdles (Haidar et al. 2024) [27]. The reliance on artificial intelligence and machine learning techniques is increasingly recognized as a crucial component in overcoming these challenges, as they can enhance predictive modeling and diagnostic accuracy by efficiently processing and analyzing large volumes of multi-omics data (Wolde et al. 2025) [26].

In summary, while multi-omics integration advances genomics by providing a holistic view of biological systems and enhancing our understanding of complex diseases, it is accompanied by notable challenges. These include computational difficulties related to data integration, the need for specialized methodologies, and the significant resources required for effective analysis. Ongoing innovation in computational techniques and collaborative efforts among researchers will be essential to address these challenges and unlock the full potential of multi-omics in genomic research and clinical applications.

5.3 Ethical Considerations in Multi-Omics Research ​

Multi-omics integration significantly advances genomics by providing a comprehensive understanding of biological systems through the integration of various omics data, including genomics, transcriptomics, proteomics, and metabolomics. This holistic approach facilitates the elucidation of complex interactions and regulatory mechanisms underlying biological processes, enabling researchers to gain insights into disease mechanisms, improve diagnostic accuracy, and tailor therapeutic strategies. For instance, multi-omics integration can enhance early disease detection and prevention, aid in biomarker discovery, and identify molecular targets for innovative drug development or the repurposing of existing therapies (Srivastava 2025; Mohr et al. 2024).

However, the integration of multi-omics data is not without its challenges and limitations. The complexity of quantitative integration poses significant hurdles, as it requires highly specialized computational methods to synthesize diverse data types effectively. Issues such as data heterogeneity, scalability, and the need for robust, interpretable models complicate the integration process (Luo et al. 2024; Liu et al. 2024). Moreover, the rapid growth of multi-omics publications indicates an increasing interest, yet it also highlights the necessity for standardized protocols and interdisciplinary collaboration to ensure data quality and reproducibility (Mohr et al. 2024).

Ethical considerations in multi-omics research are paramount, particularly regarding the management of sensitive health information. The integration of AI-driven bioinformatics in multi-omics raises concerns about data privacy, informed consent, and the potential for misuse of genomic data (Srivastava 2025). Additionally, the complexity and potential for bias in data interpretation necessitate transparent methodologies and ethical guidelines to protect participants' rights and ensure the responsible use of multi-omics technologies in clinical settings (Liu et al. 2024; Tarazona et al. 2021).

In summary, while multi-omics integration holds great promise for advancing genomics and personalized medicine, addressing the associated challenges and ethical implications is crucial for its successful application in healthcare. This includes developing robust computational frameworks, establishing ethical standards, and fostering collaboration among diverse scientific disciplines to maximize the potential of multi-omics approaches in understanding and treating diseases.

6 Future Directions in Multi-Omics Research ​

6.1 Advances in Technology and Methodology ​

Multi-omics integration significantly advances genomics by providing a comprehensive understanding of biological systems through the synergistic analysis of data derived from various omics layers, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This integrative approach enables researchers to uncover complex interactions and regulatory mechanisms that underlie biological processes and diseases, thus enhancing the precision and efficacy of genomic research.

Recent advancements in multi-omics technologies have facilitated the integration of diverse data types, allowing for a more holistic view of the molecular landscape. For instance, spatial multi-omics has emerged as a crucial development, addressing the limitations of traditional single-cell sequencing by retaining spatial context among cell populations. This method integrates genomic, transcriptomic, proteomic, and metabolomic data, enhancing our understanding of cellular biology and the molecular basis of diseases, including cancer. The integration of these datasets has proven vital in revealing spatial heterogeneity, constructing detailed spatial atlases, and advancing translational research through precise spatial mapping (Liu et al. 2024) [2].

Moreover, computational methodologies such as deep learning, graph neural networks (GNNs), and generative adversarial networks (GANs) have been pivotal in synthesizing and interpreting multi-omics data. These advanced techniques facilitate the identification of meaningful biomarkers and therapeutic targets, ultimately contributing to personalized medicine. For example, the application of large language models in multi-omics analysis can enhance feature extraction and knowledge integration, addressing challenges related to data heterogeneity and scalability (Luo et al. 2024) [4].

Future directions in multi-omics research are poised to focus on several key areas. The integration of single-cell multi-omics and artificial intelligence (AI) technologies is expected to enhance diagnostic precision and therapeutic outcomes, particularly in complex diseases like cancer. AI-driven bioinformatics tools can automate feature extraction and aid in the prioritization of therapeutic strategies based on multi-omics profiles, thereby facilitating early disease detection and treatment monitoring (Srivastava 2025) [9].

Furthermore, the development of innovative frameworks such as SynOmics, which utilizes graph convolutional networks to model cross-omics interactions, represents a significant leap forward in the integration of multi-omics data. This approach allows for the simultaneous learning of intra-omics and inter-omics relationships, thereby improving the accuracy and interpretability of predictive models (Alif & Zhang 2025) [12].

In summary, multi-omics integration advances genomics by providing a multifaceted understanding of biological systems, enhancing the discovery of biomarkers, and fostering the development of personalized therapeutic strategies. The continued evolution of technology and methodology in this field will likely yield profound implications for genomics and precision medicine, addressing existing challenges and unlocking new avenues for research and clinical applications.

6.2 Personalized Medicine and Clinical Applications ​

Multi-omics integration represents a transformative approach in genomics, significantly advancing our understanding of biological systems and enhancing personalized medicine. By combining data from various omics layers—such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics—researchers can gain a comprehensive view of the molecular mechanisms underlying complex traits and diseases.

The integration of multi-omics data is essential for achieving a deeper functional understanding of biological systems. It allows for the elucidation of intricate relationships between genes, proteins, metabolites, and phenotypic traits, thereby providing insights into how these components interact within cellular networks. This comprehensive perspective is particularly valuable in precision medicine, where the goal is to tailor treatments based on individual molecular profiles. For instance, multi-omics approaches can identify specific biomarkers for disease diagnosis and prognosis, leading to more effective and personalized therapeutic strategies [10][28].

Future directions in multi-omics research emphasize the need for improved integration techniques and the development of robust computational frameworks to analyze the vast amounts of data generated. The integration of advanced bioinformatics tools, including artificial intelligence (AI) and machine learning, is crucial for addressing the challenges associated with multi-omics data. These technologies can facilitate the identification of novel biomarkers, optimize treatment plans, and enhance the understanding of disease mechanisms [9][14].

Moreover, the integration of spatial multi-omics is emerging as a significant advancement, providing insights into the spatial organization of cellular components and their interactions within tissues. This approach enhances the understanding of disease progression and the tumor microenvironment, which is vital for developing targeted therapies in oncology [2][29].

In summary, multi-omics integration is advancing genomics by enabling a holistic understanding of biological processes and fostering the development of personalized medicine. As research continues to evolve, the integration of diverse omics data will be pivotal in uncovering the complexities of human health and disease, ultimately leading to more effective and tailored therapeutic interventions [6][25].

6.3 Collaborative Efforts and Data Sharing Initiatives ​

Multi-omics integration represents a transformative approach in genomics, facilitating a comprehensive understanding of biological systems by combining data from various omics layers, including genomics, transcriptomics, proteomics, metabolomics, and more. This integrative methodology not only enhances the characterization of biological elements but also elucidates the complex interactions and regulatory mechanisms that underlie various biological processes.

One significant advancement attributed to multi-omics integration is its ability to address the limitations of single-omics studies, which often fail to capture the holistic nature of biological systems. For instance, while genomics provides insights into the genetic blueprint, it is the integration with transcriptomics and proteomics that reveals how these genes are expressed and translated into functional proteins, thereby enhancing our understanding of phenotypic traits and disease mechanisms (Luo et al. 2024; Menyhárt & Győrffy 2021). The comprehensive nature of multi-omics approaches allows researchers to construct detailed molecular networks, paving the way for improved diagnostic and therapeutic strategies.

Looking toward future directions, the advancement of computational methodologies is critical. The incorporation of machine learning, deep learning, and other artificial intelligence techniques into multi-omics analysis is expected to enhance data integration, allowing for more robust predictions and interpretations of complex biological data (Luo et al. 2024; Alif & Zhang 2025). Moreover, the development of frameworks such as SynOmics aims to improve multi-omics integration by capturing cross-omics feature interactions, thereby facilitating a deeper understanding of disease mechanisms and potential therapeutic targets (Alif & Zhang 2025).

Collaborative efforts and data-sharing initiatives are also paramount in advancing multi-omics research. The integration of diverse datasets from multiple research groups can significantly enhance the robustness of findings and accelerate the discovery of novel biomarkers and therapeutic targets. Initiatives that promote the standardization of sample processing and analytical pipelines are essential to facilitate the translatability of multi-omics findings into clinical applications (Menyhárt & Győrffy 2021; Milner & Lennerz 2024). Furthermore, interdisciplinary collaboration among genomics, bioinformatics, and clinical researchers will be vital in overcoming the challenges associated with data heterogeneity and scalability, ultimately driving forward the field of precision medicine (Zhang et al. 2022; Luo et al. 2024).

In summary, multi-omics integration advances genomics by providing a holistic view of biological systems, enhancing our understanding of disease mechanisms, and facilitating the discovery of novel therapeutic targets. Future directions in this field will hinge on advanced computational techniques and collaborative efforts that emphasize data sharing and standardization, which are essential for translating multi-omics research into clinical practice.

7 Conclusion ​

Multi-omics integration has emerged as a transformative force in the field of genomics, providing unprecedented insights into the complex biological systems that underpin health and disease. This integrative approach enhances our understanding of the intricate interactions among various molecular layers, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics. The current research landscape demonstrates significant advancements in areas such as cancer research, metabolic disorders, and infectious diseases, where multi-omics strategies have facilitated the identification of novel biomarkers and therapeutic targets, leading to improved diagnostic and treatment strategies. However, the field faces considerable challenges, including data heterogeneity, computational complexities, and ethical considerations that must be addressed to fully realize the potential of multi-omics integration in clinical applications. Future research directions will focus on advancing technology and methodologies, fostering collaborative efforts, and enhancing data sharing initiatives, all of which are crucial for the successful application of multi-omics approaches in personalized medicine and precision healthcare. By overcoming existing challenges and leveraging the strengths of multi-omics integration, researchers can continue to unlock new avenues for understanding the molecular basis of diseases and developing innovative therapeutic strategies.

References ​

  • [1] Konrad J Karczewski;Michael P Snyder. Integrative omics for health and disease.. Nature reviews. Genetics(IF=52.0). 2018. PMID:29479082. DOI: 10.1038/nrg.2018.4.
  • [2] Xiaojie Liu;Ting Peng;Miaochun Xu;Shitong Lin;Bai Hu;Tian Chu;Binghan Liu;Yashi Xu;Wencheng Ding;Li Li;Canhui Cao;Peng Wu. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications.. Journal of hematology & oncology(IF=40.4). 2024. PMID:39182134. DOI: 10.1186/s13045-024-01596-9.
  • [3] Yuqing Liu;Feng Gao;Yang Cheng;Liang Qi;Haining Yu. Applications and advances of multi-omics technologies in gastrointestinal tumors.. Frontiers in medicine(IF=3.0). 2025. PMID:40771479. DOI: 10.3389/fmed.2025.1630788.
  • [4] Yunqing Luo;Chengjun Zhao;Fei Chen. Multiomics Research: Principles and Challenges in Integrated Analysis.. Biodesign research(IF=4.7). 2024. PMID:39990095. DOI: 10.34133/bdr.0059.
  • [5] Bing-Liang Fan;Lin-Hua Chen;Ling-Ling Chen;Hao Guo. Integrative Multi-Omics Approaches for Identifying and Characterizing Biological Elements in Crop Traits: Current Progress and Future Prospects.. International journal of molecular sciences(IF=4.9). 2025. PMID:40003933. DOI: 10.3390/ijms26041466.
  • [6] Ru Zhang;Cuiping Zhang;Chengyu Yu;Jungang Dong;Jihong Hu. Integration of multi-omics technologies for crop improvement: Status and prospects.. Frontiers in bioinformatics(IF=3.9). 2022. PMID:36438626. DOI: 10.3389/fbinf.2022.1027457.
  • [7] Otília Menyhárt;Balázs Győrffy. Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis.. Computational and structural biotechnology journal(IF=4.1). 2021. PMID:33613862. DOI: 10.1016/j.csbj.2021.01.009.
  • [8] Chongyang Chen;Jing Wang;Donghui Pan;Xinyu Wang;Yuping Xu;Junjie Yan;Lizhen Wang;Xifei Yang;Min Yang;Gong-Ping Liu. Applications of multi-omics analysis in human diseases.. MedComm(IF=10.7). 2023. PMID:37533767. DOI: 10.1002/mco2.315.
  • [9] Ruby Srivastava. Advancing precision oncology with AI-powered genomic analysis.. Frontiers in pharmacology(IF=4.8). 2025. PMID:40371349. DOI: 10.3389/fphar.2025.1591696.
  • [10] Danny A Milner;Jochen K Lennerz. Technology and Future of Multi-Cancer Early Detection.. Life (Basel, Switzerland)(IF=3.4). 2024. PMID:39063587. DOI: 10.3390/life14070833.
  • [11] Yaodong Yang;Mumtaz Ali Saand;Liyun Huang;Walid Badawy Abdelaal;Jun Zhang;Yi Wu;Jing Li;Muzafar Hussain Sirohi;Fuyou Wang. Applications of Multi-Omics Technologies for Crop Improvement.. Frontiers in plant science(IF=4.8). 2021. PMID:34539683. DOI: 10.3389/fpls.2021.563953.
  • [12] Muhtasim Noor Alif;Wei Zhang. SynOmics: integrating multi-omics data through feature interaction networks.. Briefings in bioinformatics(IF=7.7). 2025. PMID:41231214. DOI: 10.1093/bib/bbaf595.
  • [13] Li Yan;Pengxiao Su;Xiaoke Sun. Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review).. Molecular medicine reports(IF=3.5). 2025. PMID:40116118. DOI: .
  • [14] Hong Liang;Haoran Luo;Zhiling Sang;Miao Jia;Xiaohan Jiang;Zheng Wang;Shan Cong;Xiaohui Yao. GREMI: An Explainable Multi-Omics Integration Framework for Enhanced Disease Prediction and Module Identification.. IEEE journal of biomedical and health informatics(IF=6.8). 2024. PMID:39110558. DOI: 10.1109/JBHI.2024.3439713.
  • [15] Sana Hachem;Amani Yehya;Jad El Masri;Nicole Mavingire;Jabril R Johnson;Abdulrahman M Dwead;Naim Kattour;Yazan Bouchi;Firas Kobeissy;Soroush Rais-Bahrami;Yehia Mechref;Wassim Abou-Kheir;Leanne Woods-Burnham. Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.. Biology(IF=3.5). 2024. PMID:39452071. DOI: 10.3390/biology13100762.
  • [16] Guo Zhao;Yuning Wang;Shuhang Wang;Ning Li. Comprehensive multi-omics analysis provides biological insights and therapeutic strategies for small-cell lung cancer.. MedComm(IF=10.7). 2024. PMID:38817653. DOI: 10.1002/mco2.569.
  • [17] Sohini Chakraborty;Gaurav Sharma;Sricheta Karmakar;Satarupa Banerjee. Multi-OMICS approaches in cancer biology: New era in cancer therapy.. Biochimica et biophysica acta. Molecular basis of disease(IF=4.2). 2024. PMID:38484941. DOI: 10.1016/j.bbadis.2024.167120.
  • [18] Jianbo Fu;Vito R T Zanotelli;Cedric Howald;Nylsa Chammartin;Ilya Kolpakov;Ioannis Xenarios;D Sean Froese;Bernd Wollscheid;Patrick G A Pedrioli;Sandra Goetze. A Multi-Omics Framework for Decoding Disease Mechanisms: Insights From Methylmalonic Aciduria.. Molecular & cellular proteomics : MCP(IF=5.5). 2025. PMID:40436252. DOI: 10.1016/j.mcpro.2025.100998.
  • [19] Mingcheng Wang;Shuqiao Zhang;Rui Li;Qi Zhao. Unraveling the specialized metabolic pathways in medicinal plant genomes: a review.. Frontiers in plant science(IF=4.8). 2024. PMID:39777086. DOI: 10.3389/fpls.2024.1459533.
  • [20] Alyaa Elrashedy;Walid Mousa;Mohamed Nayel;Akram Salama;Ahmed Zaghawa;Ahmed Elsify;Mohamed E Hasan. Advances in bioinformatics and multi-omics integration: transforming viral infectious disease research in veterinary medicine.. Virology journal(IF=3.8). 2025. PMID:39891257. DOI: 10.1186/s12985-025-02640-x.
  • [21] Sara S Ali;Qifei Li;Pankaj B Agrawal. Implementation of multi-omics in diagnosis of pediatric rare diseases.. Pediatric research(IF=3.1). 2025. PMID:39562738. DOI: 10.1038/s41390-024-03728-w.
  • [22] Giovanni Maria De Filippis;Domenico Amalfitano;Cristiano Russo;Cristian Tommasino;Antonio Maria Rinaldi. A systematic mapping study of semantic technologies in multi-omics data integration.. Journal of biomedical informatics(IF=4.5). 2025. PMID:40154721. DOI: 10.1016/j.jbi.2025.104809.
  • [23] Getnet Molla;Molalegne Bitew. Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives.. Biomedicines(IF=3.9). 2024. PMID:39767657. DOI: 10.3390/biomedicines12122750.
  • [24] Omar Ramos-Lopez;J Alfredo Martinez;Fermin I Milagro. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.. Nutrients(IF=5.0). 2022. PMID:36235725. DOI: 10.3390/nu14194074.
  • [25] Tonci Ivanisevic;Raj N Sewduth. Multi-Omics Integration for the Design of Novel Therapies and the Identification of Novel Biomarkers.. Proteomes(IF=3.6). 2023. PMID:37873876. DOI: 10.3390/proteomes11040034.
  • [26] Tesfaye Wolde;Vipul Bhardwaj;Vijay Pandey. Current Bioinformatics Tools in Precision Oncology.. MedComm(IF=10.7). 2025. PMID:40636286. DOI: 10.1002/mco2.70243.
  • [27] Siwar Haidar;Julia Hooker;Simon Lackey;Mohamad Elian;Nathalie Puchacz;Krzysztof Szczyglowski;Frédéric Marsolais;Ashkan Golshani;Elroy R Cober;Bahram Samanfar. Harnessing Multi-Omics Strategies and Bioinformatics Innovations for Advancing Soybean Improvement: A Comprehensive Review.. Plants (Basel, Switzerland)(IF=4.1). 2024. PMID:39409584. DOI: 10.3390/plants13192714.
  • [28] Haibin Zhao;Zhigang Zhang;Hongyu Liu;Mingxiu Ma;Peng Sun;Yang Zhao;Xun Liu. Multi-omics perspective: mechanisms of gastrointestinal injury repair.. Burns & trauma(IF=9.6). 2025. PMID:39845194. DOI: 10.1093/burnst/tkae057.
  • [29] Ada Junquera;Anniina Färkkilä. Tracing cancer progression through interpretable spatial multi-omics.. Trends in cancer(IF=17.5). 2025. PMID:41260975. DOI: 10.1016/j.trecan.2025.11.002.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

multi-omics integration · genomics · personalized medicine · biomarkers · data heterogeneity

© 2025 MaltSci